This report contains market size and forecasts of Gene Knockdown in Global, including the following market information:
Global Gene Knockdown Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Gene Knockdown market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gene Knockdown companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Knockdown Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Gene Knockdown Market Segment Percentages, By Type, 2020 (%)
siRNA
shRNA
Other
China Gene Knockdown Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Gene Knockdown Market Segment Percentages, By Application, 2020 (%)
Medical
Bioengineering
Other
Global Gene Knockdown Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Gene Knockdown Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Gene Knockdown Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Gene Knockdown Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Santa Cruz Biotechnology (US)
OriGene (US)
Sigma-Aldrich (US)
Abnova (Taiwan)
Agilent Technologies (US)
Bio-Rad (US)
Cell Signaling Technology (US)
GeneCopoeia (US)
siTOOLs Biotech (Germany)
Novus Biologicals (US)
EMD Millipore (US)
BioVision (US)
Creative Biomart (US)
Selleck Chemicals (US)
MyBioSource (US)
Invitrogen (US)
Qiagen (Germany)
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Gene Knockdown Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Knockdown Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Knockdown Overall Market Size
2.1 Global Gene Knockdown Market Size: 2021 VS 2027
2.2 Global Gene Knockdown Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene Knockdown Players in Global Market
3.2 Top Global Gene Knockdown Companies Ranked by Revenue
3.3 Global Gene Knockdown Revenue by Companies
3.4 Top 3 and Top 5 Gene Knockdown Companies in Global Market, by Revenue in 2020
3.5 Global Companies Gene Knockdown Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Knockdown Players in Global Market
3.6.1 List of Global Tier 1 Gene Knockdown Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene Knockdown Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gene Knockdown Market Size Markets, 2021 & 2027
4.1.2 siRNA
4.1.3 shRNA
4.1.4 Other
4.2 By Type - Global Gene Knockdown Revenue & Forecasts
4.2.1 By Type - Global Gene Knockdown Revenue, 2016-2021
4.2.2 By Type - Global Gene Knockdown Revenue, 2022-2027
4.2.3 By Type - Global Gene Knockdown Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene Knockdown Market Size, 2021 & 2027
5.1.2 Medical
5.1.3 Bioengineering
5.1.4 Other
5.2 By Application - Global Gene Knockdown Revenue & Forecasts
5.2.1 By Application - Global Gene Knockdown Revenue, 2016-2021
5.2.2 By Application - Global Gene Knockdown Revenue, 2022-2027
5.2.3 By Application - Global Gene Knockdown Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Gene Knockdown Market Size, 2021 & 2027
6.2 By Region - Global Gene Knockdown Revenue & Forecasts
6.2.1 By Region - Global Gene Knockdown Revenue, 2016-2021
6.2.2 By Region - Global Gene Knockdown Revenue, 2022-2027
6.2.3 By Region - Global Gene Knockdown Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Gene Knockdown Revenue, 2016-2027
6.3.2 US Gene Knockdown Market Size, 2016-2027
6.3.3 Canada Gene Knockdown Market Size, 2016-2027
6.3.4 Mexico Gene Knockdown Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Gene Knockdown Revenue, 2016-2027
6.4.2 Germany Gene Knockdown Market Size, 2016-2027
6.4.3 France Gene Knockdown Market Size, 2016-2027
6.4.4 U.K. Gene Knockdown Market Size, 2016-2027
6.4.5 Italy Gene Knockdown Market Size, 2016-2027
6.4.6 Russia Gene Knockdown Market Size, 2016-2027
6.4.7 Nordic Countries Gene Knockdown Market Size, 2016-2027
6.4.8 Benelux Gene Knockdown Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Gene Knockdown Revenue, 2016-2027
6.5.2 China Gene Knockdown Market Size, 2016-2027
6.5.3 Japan Gene Knockdown Market Size, 2016-2027
6.5.4 South Korea Gene Knockdown Market Size, 2016-2027
6.5.5 Southeast Asia Gene Knockdown Market Size, 2016-2027
6.5.6 India Gene Knockdown Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Gene Knockdown Revenue, 2016-2027
6.6.2 Brazil Gene Knockdown Market Size, 2016-2027
6.6.3 Argentina Gene Knockdown Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene Knockdown Revenue, 2016-2027
6.7.2 Turkey Gene Knockdown Market Size, 2016-2027
6.7.3 Israel Gene Knockdown Market Size, 2016-2027
6.7.4 Saudi Arabia Gene Knockdown Market Size, 2016-2027
6.7.5 UAE Gene Knockdown Market Size, 2016-2027
7 Players Profiles
7.1 Santa Cruz Biotechnology (US)
7.1.1 Santa Cruz Biotechnology (US) Corporate Summary
7.1.2 Santa Cruz Biotechnology (US) Business Overview
7.1.3 Santa Cruz Biotechnology (US) Gene Knockdown Major Product Offerings
7.1.4 Santa Cruz Biotechnology (US) Gene Knockdown Revenue in Global (2016-2021)
7.1.5 Santa Cruz Biotechnology (US) Key News
7.2 OriGene (US)
7.2.1 OriGene (US) Corporate Summary
7.2.2 OriGene (US) Business Overview
7.2.3 OriGene (US) Gene Knockdown Major Product Offerings
7.2.4 OriGene (US) Gene Knockdown Revenue in Global (2016-2021)
7.2.5 OriGene (US) Key News
7.3 Sigma-Aldrich (US)
7.3.1 Sigma-Aldrich (US) Corporate Summary
7.3.2 Sigma-Aldrich (US) Business Overview
7.3.3 Sigma-Aldrich (US) Gene Knockdown Major Product Offerings
7.3.4 Sigma-Aldrich (US) Gene Knockdown Revenue in Global (2016-2021)
7.3.5 Sigma-Aldrich (US) Key News
7.4 Abnova (Taiwan)
7.4.1 Abnova (Taiwan) Corporate Summary
7.4.2 Abnova (Taiwan) Business Overview
7.4.3 Abnova (Taiwan) Gene Knockdown Major Product Offerings
7.4.4 Abnova (Taiwan) Gene Knockdown Revenue in Global (2016-2021)
7.4.5 Abnova (Taiwan) Key News
7.5 Agilent Technologies (US)
7.5.1 Agilent Technologies (US) Corporate Summary
7.5.2 Agilent Technologies (US) Business Overview
7.5.3 Agilent Technologies (US) Gene Knockdown Major Product Offerings
7.5.4 Agilent Technologies (US) Gene Knockdown Revenue in Global (2016-2021)
7.5.5 Agilent Technologies (US) Key News
7.6 Bio-Rad (US)
7.6.1 Bio-Rad (US) Corporate Summary
7.6.2 Bio-Rad (US) Business Overview
7.6.3 Bio-Rad (US) Gene Knockdown Major Product Offerings
7.6.4 Bio-Rad (US) Gene Knockdown Revenue in Global (2016-2021)
7.6.5 Bio-Rad (US) Key News
7.7 Cell Signaling Technology (US)
7.7.1 Cell Signaling Technology (US) Corporate Summary
7.7.2 Cell Signaling Technology (US) Business Overview
7.7.3 Cell Signaling Technology (US) Gene Knockdown Major Product Offerings
7.4.4 Cell Signaling Technology (US) Gene Knockdown Revenue in Global (2016-2021)
7.7.5 Cell Signaling Technology (US) Key News
7.8 GeneCopoeia (US)
7.8.1 GeneCopoeia (US) Corporate Summary
7.8.2 GeneCopoeia (US) Business Overview
7.8.3 GeneCopoeia (US) Gene Knockdown Major Product Offerings
7.8.4 GeneCopoeia (US) Gene Knockdown Revenue in Global (2016-2021)
7.8.5 GeneCopoeia (US) Key News
7.9 siTOOLs Biotech (Germany)
7.9.1 siTOOLs Biotech (Germany) Corporate Summary
7.9.2 siTOOLs Biotech (Germany) Business Overview
7.9.3 siTOOLs Biotech (Germany) Gene Knockdown Major Product Offerings
7.9.4 siTOOLs Biotech (Germany) Gene Knockdown Revenue in Global (2016-2021)
7.9.5 siTOOLs Biotech (Germany) Key News
7.10 Novus Biologicals (US)
7.10.1 Novus Biologicals (US) Corporate Summary
7.10.2 Novus Biologicals (US) Business Overview
7.10.3 Novus Biologicals (US) Gene Knockdown Major Product Offerings
7.10.4 Novus Biologicals (US) Gene Knockdown Revenue in Global (2016-2021)
7.10.5 Novus Biologicals (US) Key News
7.11 EMD Millipore (US)
7.11.1 EMD Millipore (US) Corporate Summary
7.11.2 EMD Millipore (US) Business Overview
7.11.3 EMD Millipore (US) Gene Knockdown Major Product Offerings
7.11.4 EMD Millipore (US) Gene Knockdown Revenue in Global (2016-2021)
7.11.5 EMD Millipore (US) Key News
7.12 BioVision (US)
7.12.1 BioVision (US) Corporate Summary
7.12.2 BioVision (US) Business Overview
7.12.3 BioVision (US) Gene Knockdown Major Product Offerings
7.12.4 BioVision (US) Gene Knockdown Revenue in Global (2016-2021)
7.12.5 BioVision (US) Key News
7.13 Creative Biomart (US)
7.13.1 Creative Biomart (US) Corporate Summary
7.13.2 Creative Biomart (US) Business Overview
7.13.3 Creative Biomart (US) Gene Knockdown Major Product Offerings
7.13.4 Creative Biomart (US) Gene Knockdown Revenue in Global (2016-2021)
7.13.5 Creative Biomart (US) Key News
7.14 Selleck Chemicals (US)
7.14.1 Selleck Chemicals (US) Corporate Summary
7.14.2 Selleck Chemicals (US) Business Overview
7.14.3 Selleck Chemicals (US) Gene Knockdown Major Product Offerings
7.14.4 Selleck Chemicals (US) Gene Knockdown Revenue in Global (2016-2021)
7.14.5 Selleck Chemicals (US) Key News
7.15 MyBioSource (US)
7.15.1 MyBioSource (US) Corporate Summary
7.15.2 MyBioSource (US) Business Overview
7.15.3 MyBioSource (US) Gene Knockdown Major Product Offerings
7.15.4 MyBioSource (US) Gene Knockdown Revenue in Global (2016-2021)
7.15.5 MyBioSource (US) Key News
7.16 Invitrogen (US)
7.16.1 Invitrogen (US) Corporate Summary
7.16.2 Invitrogen (US) Business Overview
7.16.3 Invitrogen (US) Gene Knockdown Major Product Offerings
7.16.4 Invitrogen (US) Gene Knockdown Revenue in Global (2016-2021)
7.16.5 Invitrogen (US) Key News
7.17 Qiagen (Germany)
7.17.1 Qiagen (Germany) Corporate Summary
7.17.2 Qiagen (Germany) Business Overview
7.17.3 Qiagen (Germany) Gene Knockdown Major Product Offerings
7.17.4 Qiagen (Germany) Gene Knockdown Revenue in Global (2016-2021)
7.17.5 Qiagen (Germany) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Gene Knockdown Market Opportunities & Trends in Global Market
Table 2. Gene Knockdown Market Drivers in Global Market
Table 3. Gene Knockdown Market Restraints in Global Market
Table 4. Key Players of Gene Knockdown in Global Market
Table 5. Top Gene Knockdown Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Gene Knockdown Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Gene Knockdown Revenue Share by Companies, 2016-2021
Table 8. Global Companies Gene Knockdown Product Type
Table 9. List of Global Tier 1 Gene Knockdown Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Knockdown Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Santa Cruz Biotechnology (US)
OriGene (US)
Sigma-Aldrich (US)
Abnova (Taiwan)
Agilent Technologies (US)
Bio-Rad (US)
Cell Signaling Technology (US)
GeneCopoeia (US)
siTOOLs Biotech (Germany)
Novus Biologicals (US)
EMD Millipore (US)
BioVision (US)
Creative Biomart (US)
Selleck Chemicals (US)
MyBioSource (US)
Invitrogen (US)
Qiagen (Germany)